Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v9-FR
Language English French
Date Updated 2018-10-23 2018-09-27
Drug Identification Number 00397466 00397466
Brand name CYSTO-CONRAY II CYSTO-CONRAY II
Common or Proper name Iothalamate Meglumine Injection USP 17.2% Iothalamate Meglumine Injection USP 17.2%
Company Name LIEBEL-FLARSHEIM COMPANY LLC LIEBEL-FLARSHEIM COMPANY LLC
Ingredients IOTHALAMATE MEGLUMINE IOTHALAMATE MEGLUMINE
Strength(s) 172MG 172MG
Dosage form(s) SOLUTION SOLUTION
Route of administration URETHRAL URETHRAL
Packaging size 250 mL, 500 mL 250 mL, 500 mL
ATC code V08AA V08AA
ATC description X-RAY CONTRAST MEDIA, IODINATED X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-05-03 2017-05-03
Estimated end date 2018-10-22 2018-10-12
Actual end date 2018-10-22
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Shipment is in transit. For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com, or by fax at 1-519-751-9149. For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com, or by fax at 1-519-751-9149.
Health Canada comments